Medizone International, Inc. (OTCBB: MZEI) (http://medizoneint.com)

There are so many reasons to be excited about the AsepticSure™ hospital sterilization system — and here is another one.  No matter how hard a cleaning crew tries to clean a hospital room MRSA may linger behind.  Hospitals MUST get a handle on infections.  Medicare no longer pays for Hospital Acquired Infection treatment.   Private Insurance is following suit.  State Legislatures are jumping on board.  The recent Duke University study which put the cost to treat an MRSA infection at $60,000 per patient put this problem in perspective.

Here is yet another study which supports the use the AsepticSure™ hospital sterilization system.  A Proctor and Gamble and Clorox found MRSA in spots that normal cleaning NEVER addresses such as the bottom of desk drawers.

The Proctor and Gamble and Clorox sponsored study tested surfaces and objects in 113 offices in five cities and found the superbug MRSA, isolated in 6% of offices.  It was found more often in men’s offices on the phone, computer mouse, desktop and the bottom of desk drawers although women’s offices had more than twice the bacteria of their male counterparts.

Contact

Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone: 415-868-0300
Fax: 415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.